Vicus Capital Abbott Laboratories Transaction History

Vicus Capital

$1.12 Billion
Q3 2024

A detailed history of Vicus Capital transactions in Abbott Laboratories stock. As of the latest transaction made, Vicus Capital holds 5,019 shares of ABT stock, worth $587,875. This represents 0.05% of its overall portfolio holdings.

Number of Shares

5,019

Previous 6,025 16.7%

Holding current value

$587,875

Previous $626,000 8.63%

% of portfolio

0.05%

Previous 0.06%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$100.07 - $118.13 $100,670 - $118,838	-1,006 Reduced 16.7%	5,019 $572,000
Q2 2024 Jul 23, 2024	BUY	$100.73 - $112.44 $89,448 - $99,846	888 Added 17.29%	6,025 $626,000
Q1 2024 Apr 17, 2024	BUY	$109.52 - $120.96 $91,668 - $101,243	837 Added 19.47%	5,137 $583,000
Q4 2023 Feb 01, 2024	SELL	$90.19 - $110.4 $69,175 - $84,676	-767 Reduced 15.14%	4,300 $473,000
Q3 2023 Oct 23, 2023	BUY	$95.53 - $114.62 $74,799 - $89,747	783 Added 18.28%	5,067 $490,000
Q2 2023 Aug 17, 2023	BUY	$100.78 - $112.29 $2,721 - $3,031	27 Added 0.63%	4,284 $467,000
Q1 2023 May 02, 2023	SELL	$96.86 - $114.01 $25,571 - $30,098	-264 Reduced 5.84%	4,257 $431,000
Q4 2022 Feb 15, 2023	SELL	$95.06 - $111.52 $6,749 - $7,917	-71 Reduced 1.55%	4,521 $496,000
Q3 2022 Nov 08, 2022	BUY	$96.76 - $112.03 $1,451 - $1,680	15 Added 0.33%	4,592 $444,000
Q2 2022 Aug 10, 2022	SELL	$102.07 - $123.37 $37,459 - $45,276	-367 Reduced 7.42%	4,577 $497,000
Q1 2022 May 11, 2022	BUY	$114.02 - $139.04 $86,769 - $105,809	761 Added 18.19%	4,944 $585,000
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $483,261 - $591,727	4,183 New	4,183 $538,000
Q2 2021 Aug 10, 2021	SELL	$105.79 - $124.53 $345,086 - $406,216	-3,262 Closed	0 $0
Q1 2021 May 04, 2021	SELL	$108.84 - $128.23 $1,850 - $2,179	-17 Reduced 0.52%	3,262 $391,000
Q4 2020 Feb 01, 2021	BUY	$105.0 - $114.42 $210 - $228	2 Added 0.06%	3,279 $359,000
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $33,998 - $41,288	-371 Reduced 10.17%	3,277 $357,000
Q2 2020 Aug 03, 2020	SELL	$76.57 - $98.0 $22,741 - $29,106	-297 Reduced 7.53%	3,648 $334,000
Q1 2020 May 07, 2020	SELL	$62.82 - $91.86 $7,726 - $11,298	-123 Reduced 3.02%	3,945 $311,000
Q4 2019 Feb 04, 2020	SELL	$78.51 - $87.4 $183,477 - $204,253	-2,337 Reduced 36.49%	4,068 $353,000
Q3 2019 Nov 18, 2019	SELL	$81.84 - $88.74 $900 - $976	-11 Reduced 0.17%	6,405 $536,000
Q2 2019 Aug 08, 2019	BUY	$72.88 - $85.0 $1,020 - $1,190	14 Added 0.22%	6,416 $540,000
Q1 2019 May 02, 2019	SELL	$66.22 - $80.06 $1,125 - $1,361	-17 Reduced 0.26%	6,402 $512,000
Q4 2018 Feb 07, 2019	BUY	$65.56 - $74.27 $65 - $74	1 Added 0.02%	6,419 $464,000
Q2 2018 Aug 02, 2018	BUY	$57.57 - $63.54 $57 - $63	1 Added 0.02%	6,418 $391,000
Q1 2018 May 07, 2018	SELL	$56.27 - $63.62 $2,757 - $3,117	-49 Reduced 0.76%	6,417 $385,000
Q4 2017 Jan 25, 2018	SELL	$53.68 - $57.47 $41,065 - $43,964	-765 Reduced 10.58%	6,466 $369,000
Q3 2017 Oct 27, 2017	BUY	$48.06 - $53.64 $347,521 - $387,870	7,231	7,231 $386,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vicus Capital, based on Form 13F filings with the SEC.

News

Stay updated on Vicus Capital with notifications on news.

Account